SC dismisses PIL seeking curbs on sale of Ranbaxy drugs

The Supreme Court Tuesday dismissed a petition for prohibiting Ranbaxy from producing and marketing its alleged “adulterated” medicines in the Indian market in the wake of reports of the pharma major having sold misbranded drugs in the US. A bench of Justice A.K.Patnaik and Justice Ranjan Gogoi dismissed the Public Interest Litigation (PIL) by advocate M.L. Sharma, asking him […]

Read More…